Results 31 to 40 of about 29,898,421 (270)

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Acknowledgement to Reviewers of Information in 2016

open access: yesInformation, 2017
The editors of Information would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016.[...]
Information Editorial Office
doaj   +1 more source

Information structure as information-based partition [PDF]

open access: yes, 2007
While the Information Structure (IS) is most naturally interpreted as "structure of information", some may argue that it is structure of something else, and others may object to the use of the word "structure".
Tomioka, Satoshi
core   +2 more sources

Acknowledgement to Reviewers of Information in 2015

open access: yesInformation, 2016
The editors of Information would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2015. [...]
Information Editorial Office
doaj   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

Acknowledgement to Reviewers of Information in 2018

open access: yesInformation, 2019
Rigorous peer-review is the corner-stone of high-quality academic publishing [...]
Information Editorial Office
doaj   +1 more source

Informational Cascades Elicit Private Information [PDF]

open access: yesSSRN Electronic Journal, 2004
We introduce cheap talk in a dynamic investment model with information externalities. We first show how social learning adversely affects the credibility of cheap talk messages. Next, we show how an informational cascade makes truth‐telling incentive compatible. A separating equilibrium only exists for high‐surplus projects.
Gossner, Olivier, Melissas, Nicholas
openaire   +7 more sources

Equitability, mutual information, and the maximal information coefficient [PDF]

open access: yes, 2013
Reshef et al. recently proposed a new statistical measure, the "maximal information coefficient" (MIC), for quantifying arbitrary dependencies between pairs of stochastic quantities.
Atwal, Gurinder S., Kinney, Justin B.
core   +2 more sources

Evaluating the Utility of Paired Tumor and Germline Targeted DNA Sequencing for Pediatric Oncology Patients: A Single Institution Report

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate the diagnostic yield and utility of universal paired tumor–normal multigene panel sequencing in newly diagnosed pediatric solid and central nervous system (CNS) tumor patients and to compare the detection of germline pathogenic/likely pathogenic variants (PV/LPVs) against established clinical referral criteria for cancer ...
Natalie Waligorski   +9 more
wiley   +1 more source

A short chronicle of warfare in South Africa

open access: yesScientia Militaria, 2012
Khoisan Wars Khoisan is the collective name for the South African people known as Hottentots and Bushmen. It is compounded from the first part of Khoi Khoin (men of men) as the Hottentots called themselves, and San, the names given by the Hottentots ...
Military Information Bureau
doaj   +1 more source

Home - About - Disclaimer - Privacy